CAM
GILD icon

Chesapeake Asset Management’s Gilead Sciences GILD Stock Holding History

Chesapeake Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20
Closed -$2.24K – 405
2025
Q1 		$2.24K Hold
20
– – ﹤0.01% 313
2024
Q4 		$1.85K Buy
20
+10
+100% +$900 ﹤0.01% 289
2024
Q3 		$838 Buy
+10
New +$763 ﹤0.01% 317
2023
Q3 		– Sell
-200
Closed -$15.4K – 455
2023
Q2 		$15.4K Hold
200
– – 0.01% 219
2023
Q1 		$16.6K Buy
+200
New +$16.6K 0.02% 203
2014
Q4 		– Sell
-29,530
Closed -$3.14M – 89
2014
Q3 		$3.14M Sell
29,530
-10,560
-26% -$1.03M 1.92% 21
2014
Q2 		$3.32M Buy
+40,090
New +$3.12M 2.07% 16

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Chesapeake Asset Management's GILD Position: Q2 2025 in Review

Chesapeake Asset Management sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 20 shares — an estimated $2.24K sold.

Chesapeake Asset Management first reported a position in GILD in Q2 2014 and held it in 7 quarters. The position peaked at $3.32M in Q2 2014. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Chesapeake Asset Management reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Chesapeake Asset Management sold 20 Gilead Sciences shares in Q2 2025, an estimated $2.24K.
  • Chesapeake Asset Management first reported a position in Gilead Sciences in Q2 2014 and held it in 7 quarters.
  • Chesapeake Asset Management's Gilead Sciences position peaked at $3.32M in Q2 2014.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Chesapeake Asset Management's 13F filing for Q2 2025, filed 15 Oct 2025.